Recurrent acalculous cholecystitis and sclerosing cholangitis in a patient with X-linked hyper-immunoglobulin M syndrome

Journal of the Formosan Medical Association

Volumn 104, Issue 6, 2005, Pages 421-426

  Lin, Sheng Chieh ^a   Shyur, Shyh Dar ^a   Ma, Yi Chun ^a   Huang, Li Hsin ^a   Lee, Hung Chang ^a   Lee, Wen I ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Acalculous cholecystitis; CD40 ligand; Cholangitis, sclerosing; Genetic diseases, X linked; Immunologic deficiency syndromes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMPICILLIN; ASPARAGINASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD40 LIGAND; CEFOTAXIME; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR; TYROSINE;

ACALCULOUS CHOLECYSTITIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ENTEROCOCCUS; EXON; GENE MUTATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPERIMMUNOGLOBULINEMIA M; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MALE; PEROPERATIVE CHOLANGIOGRAPHY; PHYSICAL EXAMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECURRENT DISEASE; SCLEROSING CHOLANGITIS; ULTRASOUND; X CHROMOSOME LINKED DISORDER; ADOLESCENT; BLOOD; CHOLECYSTITIS; GENETIC LINKAGE; GENETICS; HYPERGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; LIVER; PATHOLOGY; X CHROMOSOME;

ADOLESCENT; CD40 LIGAND; CHOLANGITIS, SCLEROSING; CHOLECYSTITIS; CHROMOSOMES, HUMAN, X; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; LINKAGE (GENETICS); LIVER; MALE; RECURRENCE;

EID: 23844450707     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kroczek RA, Graf D, Brugnoni D, et al: Defective expression of CD40 ligand on T cells causes X-linked immunodeficiency with hyper-IgM. Immunol Rev 1994;138:39.
2. Banatvala N, Davies J, Kanariou M, et al: Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child 1994; 71:150-2.
3. Levy J, Espanol-Boren T, Thomas C, et al: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47-54.
4. Winkelstein JA, Marino MC, Ochs H, et al: The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 2003;82:373-84.
5. Notarangelo LD, Hayward AR: X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120:399-405.
6. Hollenbaugh D, Grosmaire LS, Kullas CD, et al: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-21.
7. Rosen FS, Kevy SV, Merier E, et al: Recurrent bacterial infections and dysgammaglobulinemia: Deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Pediatrics 1961;28:182-95.
8. Leiva JI, Etter EL, Gathe J, et al: Surgical therapy for 101 patients with acquired immunodeficiency syndrome and symptomatic cholecystitis. Am J Surg 1997;174:414-6.
9. Keaveny A, Karasik MS: Hepatobiliary and pancreatic infections on AIDS. AIDS Patient Care STDS 1998;12:347-57.
10. Hayward AR, Levy J, Facchetti F, et al: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997; 158:977-83.
11. Mieli-Vergani G, Vergani D: Sclerosing cholangitis in the paediatric patient. Best Pract Res Clin Gastroenterol 2001;15:681-90.
12. Vitellas KM, Keogan MT, Freed KS, et al: Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiographics 2000;20:959-75.
13. Abdo A, Klassen J, Urbanski S, et al: Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J Hepatol 2003;38:688-91.
14. Hadzic N, Pagliuca A, Rela M, et al: Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med 2000;342:320-4.
15. ter Borg PC, van Buuren HR, Depla AC: Bacterial cholangitis causing secondary sclerosing cholangitis: a case report. BMC Gastroenterol 2002;2:14.
16. Tanaka Y, Koshiyama H, Nakao K, et al: Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography. Endoscopy 2001;33:633-5.
17. Debray D, Pariente D, Urvoas E, et al: Sclerosing cholangitis in children. J Pediatr 1994;124:49-56.
18. Sebagh M, Farges O, Kalil A, et al: Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995; 19:81-90.
19. Kalliafas S, Ziegler DW, Flancbaum L, et al: Acute acalculous cholecystitis: incidence, risk factors, and outcome. Am Surg 1998;64:471-5.
20. Teixeira JPA, Malheiro L, Pontinha N, et al: Infectious factors in acute acalculous cholecystitis. Hepato-Gastroenterology 2002; 49:1484-6.
21. Ryu JK, Ryu KH, Kim KH: Clinical features of acute acalculous cholecystitis. J Clin Gastroenterol 2003;36:166-9.
22. Ikeda S, Kimura W, Futakawa N, et al: Acute acalculous cholecystitis with a decrease in CD4/CD8 ratio. J Gastroenterol 1997;32:268-72.
23. Notarangelo LD, Hayward AR: X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120:399-405.
24. Okolicsanyi L, Groppo M, Floreani A, et al: Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis 2003; 35:325-31.
25. Beuers U, Spengler U, Kruis W, et al: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992;16:707-14.
26. Gilger MA, Gann ME, Opekun AR, et al: Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000;31: 136-41.
27. Pardi DS, Loftus EV, Kremers WK, et al: Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124: 889-93.